These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30906642)

  • 1. SHEDding light on the role of Pragmin pseudo-kinases in cancer.
    Roche S; Lecointre C; Simon V; Labesse G
    Am J Cancer Res; 2019; 9(2):449-454. PubMed ID: 30906642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimerization of the Pragmin Pseudo-Kinase Regulates Protein Tyrosine Phosphorylation.
    Lecointre C; Simon V; Kerneur C; Allemand F; Fournet A; Montarras I; Pons JL; Gelin M; Brignatz C; Urbach S; Labesse G; Roche S
    Structure; 2018 Apr; 26(4):545-554.e4. PubMed ID: 29503074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The crystal structure of pseudokinase PEAK1 (Sugen kinase 269) reveals an unusual catalytic cleft and a novel mode of kinase fold dimerization.
    Ha BH; Boggon TJ
    J Biol Chem; 2018 Feb; 293(5):1642-1650. PubMed ID: 29212708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pseudokinases SgK269 and SgK223: A novel oncogenic alliance in human cancer.
    O'Rourke RL; Daly RJ
    Cell Adh Migr; 2018; 12(6):524-528. PubMed ID: 29105536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SHED-Dependent Oncogenic Signaling of the PEAK3 Pseudo-Kinase.
    Ounoughene Y; Fourgous E; Boublik Y; Saland E; Guiraud N; Recher C; Urbach S; Fort P; Sarry JE; Fesquet D; Roche S
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEAK3/C19orf35 pseudokinase, a new NFK3 kinase family member, inhibits CrkII through dimerization.
    Lopez ML; Lo M; Kung JE; Dudkiewicz M; Jang GM; Von Dollen J; Johnson JR; Krogan NJ; Pawłowski K; Jura N
    Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15495-15504. PubMed ID: 31311869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homo- and Heterotypic Association Regulates Signaling by the SgK269/PEAK1 and SgK223 Pseudokinases.
    Liu L; Phua YW; Lee RS; Ma X; Jenkins Y; Novy K; Humphrey ES; Chan H; Shearer R; Ong PC; Dai W; Saunders DN; Lucet IS; Daly RJ
    J Biol Chem; 2016 Oct; 291(41):21571-21583. PubMed ID: 27531744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pseudo-Kinase Double Act.
    Preuß F; Mathea S; Knapp S
    Structure; 2018 Apr; 26(4):527-528. PubMed ID: 29617648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PEAK family of pseudokinases, their role in cell signalling and cancer.
    Patel O; Roy MJ; Murphy JM; Lucet IS
    FEBS J; 2020 Oct; 287(19):4183-4197. PubMed ID: 31599110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of Lyn and the atypical kinase SgK269/PEAK1 in a basal breast cancer signaling pathway.
    Croucher DR; Hochgräfe F; Zhang L; Liu L; Lyons RJ; Rickwood D; Tactacan CM; Browne BC; Ali N; Chan H; Shearer R; Gallego-Ortega D; Saunders DN; Swarbrick A; Daly RJ
    Cancer Res; 2013 Mar; 73(6):1969-80. PubMed ID: 23378338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimerization of the Pragmin Pseudo-Kinase Regulates Protein Tyrosine Phosphorylation.
    Lecointre C; Simon V; Kerneur C; Allemand F; Fournet A; Montarras I; Pons JL; Gelin M; Brignatz C; Urbach S; Labesse G; Roche S
    Structure; 2018 Nov; 26(11):1563. PubMed ID: 30403993
    [No Abstract]   [Full Text] [Related]  

  • 12. A historical overview of protein kinases and their targeted small molecule inhibitors.
    Roskoski R
    Pharmacol Res; 2015 Oct; 100():1-23. PubMed ID: 26207888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Aurora kinases: role in cell transformation and tumorigenesis.
    Katayama H; Brinkley WR; Sen S
    Cancer Metastasis Rev; 2003 Dec; 22(4):451-64. PubMed ID: 12884918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KRAS Oncoprotein Expression Is Regulated by a Self-Governing eIF5A-PEAK1 Feed-Forward Regulatory Loop.
    Fujimura K; Wang H; Watson F; Klemke RL
    Cancer Res; 2018 Mar; 78(6):1444-1456. PubMed ID: 29321164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of PEAK1 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer through modulating ERK1/2 and JAK2 signaling.
    Ding C; Tang W; Fan X; Wang X; Wu H; Xu H; Xu W; Gao W; Wu G
    Cell Death Dis; 2018 Jul; 9(8):802. PubMed ID: 30038287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation and function of IKK and IKK-related kinases.
    Häcker H; Karin M
    Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative phosphoproteomics reveals a cluster of tyrosine kinases that mediates SRC invasive activity in advanced colon carcinoma cells.
    Leroy C; Fialin C; Sirvent A; Simon V; Urbach S; Poncet J; Robert B; Jouin P; Roche S
    Cancer Res; 2009 Mar; 69(6):2279-86. PubMed ID: 19276381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine Kinase Activation and Conformational Flexibility: Lessons from Src-Family Tyrosine Kinases.
    Meng Y; Pond MP; Roux B
    Acc Chem Res; 2017 May; 50(5):1193-1201. PubMed ID: 28426203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the protein kinome of Entamoeba histolytica.
    Anamika K; Bhattacharya A; Srinivasan N
    Proteins; 2008 May; 71(2):995-1006. PubMed ID: 18004777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Kinases and its Novel Inhibitors: Past, Present and Future Challenges.
    Pillai P; Surenya RS; Nair SV; Lakshmanan VK
    Curr Drug Targets; 2015; 16(11):1233-45. PubMed ID: 25882221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.